Guggenheim Capital’s Immatics IMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$166K Sell
16,434
-149
-0.9% -$1.57K ﹤0.01% 1666
2026
Q1
$163K Buy
16,583
+181
+1% +$1.77K ﹤0.01% 1544
2025
Q4
$172K Buy
16,402
+124
+0.8% +$1.25K ﹤0.01% 1696
2025
Q3
$139K Sell
16,278
-279
-2% -$1.72K ﹤0.01% 1537
2025
Q2
$89.1K Buy
16,557
+893
+6% +$4.43K ﹤0.01% 1568
2025
Q1
$70.6K Buy
15,664
+1,454
+10% +$7.59K ﹤0.01% 1620
2024
Q4
$101K Buy
+14,210
New +$122K ﹤0.01% 1653

Other funds holding IMTX

Guggenheim Capital's IMTX Position: Q2 2026 in Review

Guggenheim Capital reduced its Immatics (IMTX) stake by 0.9% in Q2 2026, selling an estimated $1.57K and leaving 16,434 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

Guggenheim Capital first reported a position in IMTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $172K in Q4 2025. 82 funds tracked by Wall St. Rank hold IMTX as of Q2 2026.

  • Guggenheim Capital held 16,434 shares of Immatics worth $166K as of Q2 2026.
  • Guggenheim Capital sold 149 Immatics shares in Q2 2026, an estimated $1.57K.
  • Immatics made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1666 holding.
  • Guggenheim Capital first reported a position in Immatics in Q4 2024 and has held it in 7 quarters since.
  • Guggenheim Capital's Immatics position peaked at $172K in Q4 2025.
  • 82 funds tracked by Wall St. Rank held Immatics as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.